G.V.R.K. Sharma Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas – Fort Smith

faculty

15 h-index 51 pubs 901 cited

Research Areas

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

G.V.R.K. Sharma's research focuses on pharmacological interventions and patient outcomes, particularly within gastroenterology and hematology. Recent publications investigate the association between pharmacologic anticoagulation and the risk of recurrent venous thromboembolic events in patients using Janus kinase (JAK) inhibitors. This work also examines earlier onset of acute venous thromboembolism with specific JAK inhibitors like upadacitinib compared to tofacitinib. Additionally, Sharma's work includes meta-analyses on the efficacy of reactive immunomodulator addition to infliximab monotherapy for inflammatory bowel disease, aiming to restore clinical response. Gender differences in authorship within gastroenterology clinical practice guidelines are also a subject of study, as reflected in recent publications.

Metrics

h-index: 15
Publications: 51
Citations: 901

Selected Publications

Gender Differences in the Authorship of Gastroenterology Clinical Practice Guidelines (2025) DOI
S1340 Reactive Combination Therapy by Addition of an Immunomodulator to Infliximab Monotherapy Restores Pharmacologic and Clinical Response in Inflammatory Bowel Disease: A Case Series, Systematic Review, and Meta-Analysis (2024) DOI
Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis (2024) DOI
Earlier onset of acute venous thromboembolism with upadacitinib compared with tofacitinib during Janus kinase inhibitor therapy (2024) DOI
Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis (2024) DOI